
AxoSim 2022 Year in Review
News and BlogAxoSim’s 2022 Year in Review publication highlights company achievements, technology highlights and goals moving into 2023. View the full report featuring Q&As […]
Read MoreSelection of drug candidates is a difficult and imperfect process requiring predictive modeling. Too often, animal and other preclinical models are not predictive in humans. Without this knowledge, selection of the wrong candidate can result in losses of money, time, and resources. We aim to help navigate this path by providing rodent and human predictive in vitro modeling.
Our industry leading biomimetic platforms enable us to work with our clients and partners to apply predictive data assisting in identification of better drug candidates, earlier, and more accurately and efficiently.
By providing predictive data we aim to help toxicologists and discovery scientists make informed decisions as they advance from high-throughput in vitro assays to IND-enabling studies. Our services help researchers throughout the drug development process in both a sponsored (fee-for-service) and partnered research design.
AxoSim's NerveSim® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim® is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
AxoSim’s 2022 Year in Review publication highlights company achievements, technology highlights and goals moving into 2023. View the full report featuring Q&As […]
Read MoreRead Article in The Times-Picayune | Nola.com AxoSim and New Orleans BioInnovation Center Celebrate Lab Expansion The new space will provide 2,000 […]
Read MoreAxoSim is honored to welcome Edward “Ted” Spack, PhD, as its new Executive Director of Research and Development. Ted brings more than […]
Read MoreMeet us at SOT 2023 | March 19-23 2023 | Nashville, TN We will be on the road for the SOT 2023 […]
Read MoreAt AxoSim, we frequently like to remind ourselves of our mission- empowering advancements in human neuroscience. We take a minute- away from the lab bench, protocols, schedules, budgets, and pipettes- and remember, that at the end of all the research, is people. Human beings that we know and love that are fighting daily battles with neurological diseases.